Competitive landscape
Drugs aimed at the same indication, from approved to preclinical.
7 drugs for “Urothelial Carcinoma”
Phase 3 6
- IvonescimabSummit Therapeutics Inc.Metastatic Urothelial Carcinoma; Metastatic Urothelial Carcinoma (UC) · next catalyst 14 Nov 2026
- Cretostimogene grenadenorepvecCG Oncology, Inc.Urothelial Carcinoma
- Disitamab vedotinSeagen Inc.Urothelial Carcinoma
- UGN-102UroGen Pharma Ltd.Urothelial Carcinoma; Urothelial Carcinoma Bladder
- UGN-103UroGen Pharma Ltd.Urothelial Carcinoma; Urothelial Carcinoma Bladder
- UGN-104UroGen Pharma Ltd.Upper Urinary Tract Urothelial Carcinoma; Urothelial Carcinoma
Phase 2/3 1
- Ivonescimab RP3DSummit Therapeutics Inc.Metastatic Urothelial Carcinoma; Metastatic Urothelial Carcinoma (UC)
Drugs whose recorded indications name this term, by development stage. Indications come from registries and labels, so a drug can appear under related terms.